Sign in
4

Changes in Ownership

Altimmune, Inc. Filed Acc 0001104659-21-101661

Chief Scientific Officer acquired 1,750 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Roberts M Scot Chief Scientific Officer 2021-07-31 Grant or award +1,750 $7.71 $13,492 11,611 D: show line 1 in the form
Loading xslF345X03/tm2124283-1_4seq1.xml…